Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms

Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms

BackgroundAnti-interleukin (IL)-23 agents are widely used for autoimmune disease treatment; however, the safety and risks of specific symptoms have not been systematically assessed.ObjectivesThe aim of this study was to summarize the characteristics and mechanisms of occurrence of five immunological...

Full description

Bibliographic Details
Main Authors: Yi Ru, Xiaojie Ding, Ying Luo, Hongjin Li, Xiaoying Sun, Mi Zhou, Yaqiong Zhou, Le Kuai, Meng Xing, Liu Liu, Yue Luo, Jiankun Song, Jiale Chen, Bin Li, Xin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
anti-IL-23
adverse events
meta-analysis
systematic review
biologics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.670398/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.670398/full

Similar Items